These results indicate that the inhibition of GSK-3β does not affect the nuclear accumulation of NF-κB p65 but might alter the ability of NF-κB to regulate target gene promoters in ALL cells. This evidence concerns the gene GSK3B and acute lymphoblastic leukemia.